Click for best price
SemiSolid Formulations Drug Delivery Market Size, Share 2023
The semi-solid drug category is comprised of creams, gels, ointments, suppositories, and other special topical dosage forms. Semi-solid drug formulations share many common attributes which include consistency, dosage uniformity, preservatives, the route of administration and their formulation basis.
This report aims to provide a comprehensive presentation of the global market for Semi-Solid Formulations Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Semi-Solid Formulations Drug Delivery. This report contains market size and forecasts of Semi-Solid Formulations Drug Delivery in global, including the following market information:
Global Semi-Solid Formulations Drug Delivery Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Semi-Solid Formulations Drug Delivery market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Creams Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Semi-Solid Formulations Drug Delivery include Glenmark Pharmaceuticals, Galderma, Johnson & Johnson Private, GlaxoSmithKline, Bausch Health Companies, Hisamitsu Pharmaceuticals, Cipla, Bayer and Viatris, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Semi-Solid Formulations Drug Delivery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Semi-Solid Formulations Drug Delivery Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Semi-Solid Formulations Drug Delivery Market Segment Percentages, by Type, 2022 (%)
Creams
Ointments
Lotions
Gel
Pastes
Global Semi-Solid Formulations Drug Delivery Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Semi-Solid Formulations Drug Delivery Market Segment Percentages, by Application, 2022 (%)
Home Care Settings
Hospitals & Clinics
Burn Centers
Other Facilities
Global Semi-Solid Formulations Drug Delivery Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Semi-Solid Formulations Drug Delivery Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Semi-Solid Formulations Drug Delivery revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Semi-Solid Formulations Drug Delivery revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Glenmark Pharmaceuticals
Galderma
Johnson & Johnson Private
GlaxoSmithKline
Bausch Health Companies
Hisamitsu Pharmaceuticals
Cipla
Bayer
Viatris
3M
Merck & Co
Crescita Therpeautics
Novartis International
Boehringer Ingelheim
Pfizer
Teva Pharmaceuticals
Bristol Myers Squibb
Lead Chemical
Purdue Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Semi-Solid Formulations Drug Delivery, market overview.
Chapter 2: Global Semi-Solid Formulations Drug Delivery market size in revenue.
Chapter 3: Detailed analysis of Semi-Solid Formulations Drug Delivery company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Semi-Solid Formulations Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Semi-Solid Formulations Drug Delivery Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
109 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Semi-Solid Formulations Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Semi-Solid Formulations Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Semi-Solid Formulations Drug Delivery Overall Market Size
2.1 Global Semi-Solid Formulations Drug Delivery Market Size: 2022 VS 2029
2.2 Global Semi-Solid Formulations Drug Delivery Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Semi-Solid Formulations Drug Delivery Players in Global Market
3.2 Top Global Semi-Solid Formulations Drug Delivery Companies Ranked by Revenue
3.3 Global Semi-Solid Formulations Drug Delivery Revenue by Companies
3.4 Top 3 and Top 5 Semi-Solid Formulations Drug Delivery Companies in Global Market, by Revenue in 2022
3.5 Global Companies Semi-Solid Formulations Drug Delivery Product Type
3.6 Tier 1, Tier 2 and Tier 3 Semi-Solid Formulations Drug Delivery Players in Global Market
3.6.1 List of Global Tier 1 Semi-Solid Formulations Drug Delivery Companies
3.6.2 List of Global Tier 2 and Tier 3 Semi-Solid Formulations Drug Delivery Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Semi-Solid Formulations Drug Delivery Market Size Markets, 2022 & 2029
4.1.2 Creams
4.1.3 Ointments
4.1.4 Lotions
4.1.5 Gel
4.1.6 Pastes
4.2 By Type - Global Semi-Solid Formulations Drug Delivery Revenue & Forecasts
4.2.1 By Type - Global Semi-Solid Formulations Drug Delivery Revenue, 2018-2023
4.2.2 By Type - Global Semi-Solid Formulations Drug Delivery Revenue, 2024-2029
4.2.3 By Type - Global Semi-Solid Formulations Drug Delivery Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Semi-Solid Formulations Drug Delivery Market Size, 2022 & 2029
5.1.2 Home Care Settings
5.1.3 Hospitals & Clinics
5.1.4 Burn Centers
5.1.5 Other Facilities
5.2 By Application - Global Semi-Solid Formulations Drug Delivery Revenue & Forecasts
5.2.1 By Application - Global Semi-Solid Formulations Drug Delivery Revenue, 2018-2023
5.2.2 By Application - Global Semi-Solid Formulations Drug Delivery Revenue, 2024-2029
5.2.3 By Application - Global Semi-Solid Formulations Drug Delivery Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Semi-Solid Formulations Drug Delivery Market Size, 2022 & 2029
6.2 By Region - Global Semi-Solid Formulations Drug Delivery Revenue & Forecasts
6.2.1 By Region - Global Semi-Solid Formulations Drug Delivery Revenue, 2018-2023
6.2.2 By Region - Global Semi-Solid Formulations Drug Delivery Revenue, 2024-2029
6.2.3 By Region - Global Semi-Solid Formulations Drug Delivery Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Semi-Solid Formulations Drug Delivery Revenue, 2018-2029
6.3.2 US Semi-Solid Formulations Drug Delivery Market Size, 2018-2029
6.3.3 Canada Semi-Solid Formulations Drug Delivery Market Size, 2018-2029
6.3.4 Mexico Semi-Solid Formulations Drug Delivery Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Semi-Solid Formulations Drug Delivery Revenue, 2018-2029
6.4.2 Germany Semi-Solid Formulations Drug Delivery Market Size, 2018-2029
6.4.3 France Semi-Solid Formulations Drug Delivery Market Size, 2018-2029
6.4.4 U.K. Semi-Solid Formulations Drug Delivery Market Size, 2018-2029
6.4.5 Italy Semi-Solid Formulations Drug Delivery Market Size, 2018-2029
6.4.6 Russia Semi-Solid Formulations Drug Delivery Market Size, 2018-2029
6.4.7 Nordic Countries Semi-Solid Formulations Drug Delivery Market Size, 2018-2029
6.4.8 Benelux Semi-Solid Formulations Drug Delivery Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Semi-Solid Formulations Drug Delivery Revenue, 2018-2029
6.5.2 China Semi-Solid Formulations Drug Delivery Market Size, 2018-2029
6.5.3 Japan Semi-Solid Formulations Drug Delivery Market Size, 2018-2029
6.5.4 South Korea Semi-Solid Formulations Drug Delivery Market Size, 2018-2029
6.5.5 Southeast Asia Semi-Solid Formulations Drug Delivery Market Size, 2018-2029
6.5.6 India Semi-Solid Formulations Drug Delivery Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Semi-Solid Formulations Drug Delivery Revenue, 2018-2029
6.6.2 Brazil Semi-Solid Formulations Drug Delivery Market Size, 2018-2029
6.6.3 Argentina Semi-Solid Formulations Drug Delivery Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Semi-Solid Formulations Drug Delivery Revenue, 2018-2029
6.7.2 Turkey Semi-Solid Formulations Drug Delivery Market Size, 2018-2029
6.7.3 Israel Semi-Solid Formulations Drug Delivery Market Size, 2018-2029
6.7.4 Saudi Arabia Semi-Solid Formulations Drug Delivery Market Size, 2018-2029
6.7.5 UAE Semi-Solid Formulations Drug Delivery Market Size, 2018-2029
7 Semi-Solid Formulations Drug Delivery Companies Profiles
7.1 Glenmark Pharmaceuticals
7.1.1 Glenmark Pharmaceuticals Company Summary
7.1.2 Glenmark Pharmaceuticals Business Overview
7.1.3 Glenmark Pharmaceuticals Semi-Solid Formulations Drug Delivery Major Product Offerings
7.1.4 Glenmark Pharmaceuticals Semi-Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.1.5 Glenmark Pharmaceuticals Key News & Latest Developments
7.2 Galderma
7.2.1 Galderma Company Summary
7.2.2 Galderma Business Overview
7.2.3 Galderma Semi-Solid Formulations Drug Delivery Major Product Offerings
7.2.4 Galderma Semi-Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.2.5 Galderma Key News & Latest Developments
7.3 Johnson & Johnson Private
7.3.1 Johnson & Johnson Private Company Summary
7.3.2 Johnson & Johnson Private Business Overview
7.3.3 Johnson & Johnson Private Semi-Solid Formulations Drug Delivery Major Product Offerings
7.3.4 Johnson & Johnson Private Semi-Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.3.5 Johnson & Johnson Private Key News & Latest Developments
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Semi-Solid Formulations Drug Delivery Major Product Offerings
7.4.4 GlaxoSmithKline Semi-Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.4.5 GlaxoSmithKline Key News & Latest Developments
7.5 Bausch Health Companies
7.5.1 Bausch Health Companies Company Summary
7.5.2 Bausch Health Companies Business Overview
7.5.3 Bausch Health Companies Semi-Solid Formulations Drug Delivery Major Product Offerings
7.5.4 Bausch Health Companies Semi-Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.5.5 Bausch Health Companies Key News & Latest Developments
7.6 Hisamitsu Pharmaceuticals
7.6.1 Hisamitsu Pharmaceuticals Company Summary
7.6.2 Hisamitsu Pharmaceuticals Business Overview
7.6.3 Hisamitsu Pharmaceuticals Semi-Solid Formulations Drug Delivery Major Product Offerings
7.6.4 Hisamitsu Pharmaceuticals Semi-Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.6.5 Hisamitsu Pharmaceuticals Key News & Latest Developments
7.7 Cipla
7.7.1 Cipla Company Summary
7.7.2 Cipla Business Overview
7.7.3 Cipla Semi-Solid Formulations Drug Delivery Major Product Offerings
7.7.4 Cipla Semi-Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.7.5 Cipla Key News & Latest Developments
7.8 Bayer
7.8.1 Bayer Company Summary
7.8.2 Bayer Business Overview
7.8.3 Bayer Semi-Solid Formulations Drug Delivery Major Product Offerings
7.8.4 Bayer Semi-Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.8.5 Bayer Key News & Latest Developments
7.9 Viatris
7.9.1 Viatris Company Summary
7.9.2 Viatris Business Overview
7.9.3 Viatris Semi-Solid Formulations Drug Delivery Major Product Offerings
7.9.4 Viatris Semi-Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.9.5 Viatris Key News & Latest Developments
7.10 3M
7.10.1 3M Company Summary
7.10.2 3M Business Overview
7.10.3 3M Semi-Solid Formulations Drug Delivery Major Product Offerings
7.10.4 3M Semi-Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.10.5 3M Key News & Latest Developments
7.11 Merck & Co
7.11.1 Merck & Co Company Summary
7.11.2 Merck & Co Business Overview
7.11.3 Merck & Co Semi-Solid Formulations Drug Delivery Major Product Offerings
7.11.4 Merck & Co Semi-Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.11.5 Merck & Co Key News & Latest Developments
7.12 Crescita Therpeautics
7.12.1 Crescita Therpeautics Company Summary
7.12.2 Crescita Therpeautics Business Overview
7.12.3 Crescita Therpeautics Semi-Solid Formulations Drug Delivery Major Product Offerings
7.12.4 Crescita Therpeautics Semi-Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.12.5 Crescita Therpeautics Key News & Latest Developments
7.13 Novartis International
7.13.1 Novartis International Company Summary
7.13.2 Novartis International Business Overview
7.13.3 Novartis International Semi-Solid Formulations Drug Delivery Major Product Offerings
7.13.4 Novartis International Semi-Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.13.5 Novartis International Key News & Latest Developments
7.14 Boehringer Ingelheim
7.14.1 Boehringer Ingelheim Company Summary
7.14.2 Boehringer Ingelheim Business Overview
7.14.3 Boehringer Ingelheim Semi-Solid Formulations Drug Delivery Major Product Offerings
7.14.4 Boehringer Ingelheim Semi-Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.14.5 Boehringer Ingelheim Key News & Latest Developments
7.15 Pfizer
7.15.1 Pfizer Company Summary
7.15.2 Pfizer Business Overview
7.15.3 Pfizer Semi-Solid Formulations Drug Delivery Major Product Offerings
7.15.4 Pfizer Semi-Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.15.5 Pfizer Key News & Latest Developments
7.16 Teva Pharmaceuticals
7.16.1 Teva Pharmaceuticals Company Summary
7.16.2 Teva Pharmaceuticals Business Overview
7.16.3 Teva Pharmaceuticals Semi-Solid Formulations Drug Delivery Major Product Offerings
7.16.4 Teva Pharmaceuticals Semi-Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.16.5 Teva Pharmaceuticals Key News & Latest Developments
7.17 Bristol Myers Squibb
7.17.1 Bristol Myers Squibb Company Summary
7.17.2 Bristol Myers Squibb Business Overview
7.17.3 Bristol Myers Squibb Semi-Solid Formulations Drug Delivery Major Product Offerings
7.17.4 Bristol Myers Squibb Semi-Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.17.5 Bristol Myers Squibb Key News & Latest Developments
7.18 Lead Chemical
7.18.1 Lead Chemical Company Summary
7.18.2 Lead Chemical Business Overview
7.18.3 Lead Chemical Semi-Solid Formulations Drug Delivery Major Product Offerings
7.18.4 Lead Chemical Semi-Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.18.5 Lead Chemical Key News & Latest Developments
7.19 Purdue Pharma
7.19.1 Purdue Pharma Company Summary
7.19.2 Purdue Pharma Business Overview
7.19.3 Purdue Pharma Semi-Solid Formulations Drug Delivery Major Product Offerings
7.19.4 Purdue Pharma Semi-Solid Formulations Drug Delivery Revenue in Global Market (2018-2023)
7.19.5 Purdue Pharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Semi-Solid Formulations Drug Delivery Market Opportunities & Trends in Global Market
Table 2. Semi-Solid Formulations Drug Delivery Market Drivers in Global Market
Table 3. Semi-Solid Formulations Drug Delivery Market Restraints in Global Market
Table 4. Key Players of Semi-Solid Formulations Drug Delivery in Global Market
Table 5. Top Semi-Solid Formulations Drug Delivery Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Semi-Solid Formulations Drug Delivery Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Semi-Solid Formulations Drug Delivery Revenue Share by Companies, 2018-2023
Table 8. Global Companies Semi-Solid Formulations Drug Delivery Product Type
Table 9. List of Global Tier 1 Semi-Solid Formulations Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Semi-Solid Formulations Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Semi-Solid Formulations Drug Delivery Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Semi-Solid Formulations Drug Delivery Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Semi-Solid Formulations Drug Delivery Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Semi-Solid Formulations Drug Delivery Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Semi-Solid Formulations Drug Delivery Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Semi-Solid Formulations Drug Delivery Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 30. Glenmark Pharmaceuticals Company Summary
Table 31. Glenmark Pharmaceuticals Semi-Solid Formulations Drug Delivery Product Offerings
Table 32. Glenmark Pharmaceuticals Semi-Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 33. Glenmark Pharmaceuticals Key News & Latest Developments
Table 34. Galderma Company Summary
Table 35. Galderma Semi-Solid Formulations Drug Delivery Product Offerings
Table 36. Galderma Semi-Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 37. Galderma Key News & Latest Developments
Table 38. Johnson & Johnson Private Company Summary
Table 39. Johnson & Johnson Private Semi-Solid Formulations Drug Delivery Product Offerings
Table 40. Johnson & Johnson Private Semi-Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 41. Johnson & Johnson Private Key News & Latest Developments
Table 42. GlaxoSmithKline Company Summary
Table 43. GlaxoSmithKline Semi-Solid Formulations Drug Delivery Product Offerings
Table 44. GlaxoSmithKline Semi-Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 45. GlaxoSmithKline Key News & Latest Developments
Table 46. Bausch Health Companies Company Summary
Table 47. Bausch Health Companies Semi-Solid Formulations Drug Delivery Product Offerings
Table 48. Bausch Health Companies Semi-Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 49. Bausch Health Companies Key News & Latest Developments
Table 50. Hisamitsu Pharmaceuticals Company Summary
Table 51. Hisamitsu Pharmaceuticals Semi-Solid Formulations Drug Delivery Product Offerings
Table 52. Hisamitsu Pharmaceuticals Semi-Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 53. Hisamitsu Pharmaceuticals Key News & Latest Developments
Table 54. Cipla Company Summary
Table 55. Cipla Semi-Solid Formulations Drug Delivery Product Offerings
Table 56. Cipla Semi-Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 57. Cipla Key News & Latest Developments
Table 58. Bayer Company Summary
Table 59. Bayer Semi-Solid Formulations Drug Delivery Product Offerings
Table 60. Bayer Semi-Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 61. Bayer Key News & Latest Developments
Table 62. Viatris Company Summary
Table 63. Viatris Semi-Solid Formulations Drug Delivery Product Offerings
Table 64. Viatris Semi-Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 65. Viatris Key News & Latest Developments
Table 66. 3M Company Summary
Table 67. 3M Semi-Solid Formulations Drug Delivery Product Offerings
Table 68. 3M Semi-Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 69. 3M Key News & Latest Developments
Table 70. Merck & Co Company Summary
Table 71. Merck & Co Semi-Solid Formulations Drug Delivery Product Offerings
Table 72. Merck & Co Semi-Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 73. Merck & Co Key News & Latest Developments
Table 74. Crescita Therpeautics Company Summary
Table 75. Crescita Therpeautics Semi-Solid Formulations Drug Delivery Product Offerings
Table 76. Crescita Therpeautics Semi-Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 77. Crescita Therpeautics Key News & Latest Developments
Table 78. Novartis International Company Summary
Table 79. Novartis International Semi-Solid Formulations Drug Delivery Product Offerings
Table 80. Novartis International Semi-Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 81. Novartis International Key News & Latest Developments
Table 82. Boehringer Ingelheim Company Summary
Table 83. Boehringer Ingelheim Semi-Solid Formulations Drug Delivery Product Offerings
Table 84. Boehringer Ingelheim Semi-Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 85. Boehringer Ingelheim Key News & Latest Developments
Table 86. Pfizer Company Summary
Table 87. Pfizer Semi-Solid Formulations Drug Delivery Product Offerings
Table 88. Pfizer Semi-Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 89. Pfizer Key News & Latest Developments
Table 90. Teva Pharmaceuticals Company Summary
Table 91. Teva Pharmaceuticals Semi-Solid Formulations Drug Delivery Product Offerings
Table 92. Teva Pharmaceuticals Semi-Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 93. Teva Pharmaceuticals Key News & Latest Developments
Table 94. Bristol Myers Squibb Company Summary
Table 95. Bristol Myers Squibb Semi-Solid Formulations Drug Delivery Product Offerings
Table 96. Bristol Myers Squibb Semi-Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 97. Bristol Myers Squibb Key News & Latest Developments
Table 98. Lead Chemical Company Summary
Table 99. Lead Chemical Semi-Solid Formulations Drug Delivery Product Offerings
Table 100. Lead Chemical Semi-Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 101. Lead Chemical Key News & Latest Developments
Table 102. Purdue Pharma Company Summary
Table 103. Purdue Pharma Semi-Solid Formulations Drug Delivery Product Offerings
Table 104. Purdue Pharma Semi-Solid Formulations Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 105. Purdue Pharma Key News & Latest Developments
List of Figures
Figure 1. Semi-Solid Formulations Drug Delivery Segment by Type in 2022
Figure 2. Semi-Solid Formulations Drug Delivery Segment by Application in 2022
Figure 3. Global Semi-Solid Formulations Drug Delivery Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Semi-Solid Formulations Drug Delivery Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Semi-Solid Formulations Drug Delivery Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Semi-Solid Formulations Drug Delivery Revenue in 2022
Figure 8. By Type - Global Semi-Solid Formulations Drug Delivery Revenue Market Share, 2018-2029
Figure 9. By Application - Global Semi-Solid Formulations Drug Delivery Revenue Market Share, 2018-2029
Figure 10. By Type - Global Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Semi-Solid Formulations Drug Delivery Revenue Market Share, 2018-2029
Figure 12. By Application - Global Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Semi-Solid Formulations Drug Delivery Revenue Market Share, 2018-2029
Figure 14. By Region - Global Semi-Solid Formulations Drug Delivery Revenue Market Share, 2018-2029
Figure 15. By Country - North America Semi-Solid Formulations Drug Delivery Revenue Market Share, 2018-2029
Figure 16. US Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Semi-Solid Formulations Drug Delivery Revenue Market Share, 2018-2029
Figure 20. Germany Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 21. France Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Semi-Solid Formulations Drug Delivery Revenue Market Share, 2018-2029
Figure 28. China Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 32. India Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Semi-Solid Formulations Drug Delivery Revenue Market Share, 2018-2029
Figure 34. Brazil Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Semi-Solid Formulations Drug Delivery Revenue Market Share, 2018-2029
Figure 37. Turkey Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 41. Glenmark Pharmaceuticals Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Galderma Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Johnson & Johnson Private Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. GlaxoSmithKline Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bausch Health Companies Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Hisamitsu Pharmaceuticals Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Cipla Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Bayer Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Viatris Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. 3M Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Merck & Co Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Crescita Therpeautics Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Novartis International Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Boehringer Ingelheim Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Pfizer Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Teva Pharmaceuticals Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Bristol Myers Squibb Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Lead Chemical Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Purdue Pharma Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
